NIH-funded research R01 grant

Reducing artery narrowing after vascular surgery

Official title: Targeted suppression of ALDH1A3 for endothelial beneficial management of restenosis after vascular surgery

Funded at University of Virginia · NIH-11177762 · Data updated 2026-11-12

This study is looking at how lowering a certain protein called ALDH1A3 might help your blood vessels heal better after procedures like angioplasty, which could lead to fewer complications and better recovery for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startAugust 26, 2024
Project endMay 31, 2028
Funding year2025
Award (this year)$719,626
NIH project number5R01HL171140-02
Project IDNIH-11177762 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals scheduled for angioplasty or similar vascular procedures.

Less likely to help

Patients who have not undergone vascular surgery or have conditions unrelated to arterial health may not benefit from this research.

What this research studies

This research investigates how targeting a specific protein, ALDH1A3, can help improve the healing of blood vessels after procedures like angioplasty. By using advanced techniques to reduce the levels of ALDH1A3, the study aims to enhance the recovery of endothelial cells, which line the blood vessels, and prevent complications such as inflammation and re-narrowing of the arteries. The approach includes both laboratory experiments and animal models to test the effectiveness of this targeted therapy. Patients may benefit from improved outcomes following vascular surgeries if the findings are successful.

Why it matters

Potential benefit: If successful, this research could lead to better healing and reduced complications for patients undergoing vascular surgeries.

How similar studies have gone: Previous research has shown promising results in targeting ALDH1A3 for vascular health, indicating potential for success in this approach.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Kent, K Craig — University of Virginia
  • Study coordinator: Kent, K Craig

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.